GSM5034684: AML5 Relapse sample after 1 cycle of nivolumab re-exposure; Homo sapiens; RNA-Seq
Ficoll density centrifugation and bead-based dead cell removal droplet-based scRNA-seq (5' scRNA-seq) using the chromium platform (10x Genomics); surface marker staining using Total-seq C antibodies
GEO Accession
GSM5034684